BIO-Europe Spring 2019 - 13th Annual international partnering conference (March 25-27, 2019 - Vienna, Austria)
-
Asma Al-Shamahi [1]
-
[1] Clarivate Analytics, London
-
- Localización: Medicamentos de actualidad = Drugs of today, ISSN 1699-3993, Vol. 55, Nº. 5, 2019 (Ejemplar dedicado a: Mayo), págs. 345-349
- Idioma: inglés
- Texto completo no disponible (Saber más ...)
-
Resumen
Vienna was the grand setting of the 13th Annual BIO-Europe Spring partnering meeting at the Congress Centre Wien, with receptions at the Hofburg Palace and the Rathaus. Thousands of biopharma executives congregated for one-to-one meetings to discuss collaborations, investment and the inand outlicensing of assets. The 3-day conference agenda included plenary sessions, company presentations, panel discussions, partnering workshops, networking lunches and spotlight sessions. Topics of focus included the Asia-Pacific evolving biopharma landscape, investment and partnering emerging opportunities in metabesity and nonalcoholic steatohepatitis, the biopharma value chain transformation through digital technologies, microbiome therapeutics deals and upcoming trends in European biotech. This report covers highlights from the meeting.
